Lista de obras -

Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantation

artículo científico publicado en 2008

Antiviral treatment of hepatitis C.

artículo científico publicado en 2006

Biliary strictures after liver transplantation: role of interleukin 28B genotypes in cyclosporine treated

artículo científico publicado en 2014

Carriage of the apolipoprotein E-epsilon4 allele and histologic outcome of recurrent hepatitis C after antiviral treatment.

artículo científico publicado en 2004

Clinical and virological response to entecavir in HBV-related chronic hepatitis or cirrhosis: data from the clinical practice in a single-centre cohort

artículo científico publicado en 2012

Combinatorial use of single nucleotide polymorphisms to help predict liver fibrosis in patients with hepatitis C infections.

artículo científico

Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.

artículo científico publicado en 2011

Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation

artículo científico publicado en 2005

Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C

artículo científico publicado en 2013

Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C.

artículo científico publicado en 2013

Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression

artículo científico publicado en 2009

Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naive patients with chronic lymphocytic leukemia

artículo científico

PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis

artículo científico publicado en 2015

R-1626, a specific oral NS5B polymerase inhibitor of hepatitis C virus

artículo científico publicado en 2008

Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype.

artículo científico publicado en 2011

Updates on antiviral therapy for chronic hepatitis C.

artículo científico publicado en 2007

Valopicitabine dihydrochloride:a specific polymerase inhibitor of hepatitis C virus.

artículo científico publicado en 2007

Vitamin D and the risk of acute allograft rejection following human liver transplantation.

artículo científico publicado en 2009

Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C.

artículo científico publicado en 2012

Vitamin D deficiency and HCV chronic infection: what comes first?

artículo científico publicado en 2011

Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis

artículo científico publicado en 2010

Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C.

artículo científico publicado en 2011

Lista de obras de

Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantation

Antiviral treatment of hepatitis C.

Biliary strictures after liver transplantation: role of interleukin 28B genotypes in cyclosporine treated

Carriage of the apolipoprotein E-epsilon4 allele and histologic outcome of recurrent hepatitis C after antiviral treatment.

Clinical and virological response to entecavir in HBV-related chronic hepatitis or cirrhosis: data from the clinical practice in a single-centre cohort

Combinatorial use of single nucleotide polymorphisms to help predict liver fibrosis in patients with hepatitis C infections.

Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.

Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation

Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C

Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C.

Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression

Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naive patients with chronic lymphocytic leukemia

PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis

R-1626, a specific oral NS5B polymerase inhibitor of hepatitis C virus

Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype.

Updates on antiviral therapy for chronic hepatitis C.

Valopicitabine dihydrochloride:a specific polymerase inhibitor of hepatitis C virus.

Vitamin D and the risk of acute allograft rejection following human liver transplantation.

Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C.

Vitamin D deficiency and HCV chronic infection: what comes first?

Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis

Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C.